SBI Mutual Fund · #153718
SBI Nifty100 Low Volatility 30 Index Fund - Direct Plan - Growth
Other · Index Funds · Direct · Growth
Direct TER: 0.52% · as of
5-year NAV · change the window using the controls in the rolling-returns card below ↓
2025-07-31 → 2026-10-22
Latest NAV
₹9.4632
as of 2026-10-22 · -0.39% vs 2026-10-21
Earliest NAV in archive
2025-07-31
AMFI archive begins Apr 2006
Trailing CAGR vs assigned benchmark
| Window | Scheme CAGR | Benchmark CAGR | Excess | Period |
|---|---|---|---|---|
| 1y | -10.55% | — | — | 2025-10-23 → today · 1.0y |
Benchmark assignment is mapped by category and sub-category from public sources. "Since inception (in archive)" uses the earliest NAV in the AMFI archive (April 2006 onward).
Monthly returns · since inception (Jul 2025)
How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.2 | +0.3 | -10.7 | +7.3 | -0.6 | +1.0 | +4.7 | -1.7 | -7.1 | -0.8 | · | · | -11.3 |
| 2025 | · | · | · | · | · | · | · | +1.4 | -1.7 | +3.7 | +1.9 | +0.4 | +5.8 |
| Avg | -3.2 | +0.3 | -10.7 | +7.3 | -0.6 | +1.0 | +4.7 | -0.1 | -4.4 | +3.7 | +1.9 | +0.4 | · |
All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row.
Portfolio mix · asset class breakdown as of 2026-09-30
Size axis (Style Box) · Large / Mid / Small split of latest disclosed holdings
Per AMFI's semi-annual Categorisation of Stocks (top 100 = Large, 101-250 = Mid, 251+ = Small).
- Large Cap 96.8%
- Mid Cap 3.2%
Index overlap
· vs · share of this fund's AUM that sits in stocks the index also includesNo holdings data yet for this fund.
Top stocks held · 30 holdings as of 2026-09-30 See changes vs previous snapshot →
| Stock | Sector | % of fund |
|---|---|---|
| ICICI Bank Ltd. | Banks | 3.84% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 3.82% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 3.81% |
| NTPC Ltd. | Power | 3.79% |
| Britannia Industries Ltd. | Food Products | 3.68% |
| Bharti Airtel Ltd. | Telecom - Services | 3.65% |
| Kotak Mahindra Bank Ltd. | Banks | 3.63% |
| SBI Life Insurance Co. Ltd. | Insurance | 3.62% |
| Nestle India Ltd. | Food Products | 3.53% |
| ITC Ltd. | Diversified FMCG | 3.50% |
| Reliance Industries Ltd. | Petroleum Products | 3.47% |
| Tata Power Company Ltd. | Power | 3.42% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 3.42% |
| Power Grid Corporation of India Ltd. | Power | 3.39% |
| HDFC Bank Ltd. | Banks | 3.39% |
| Hindustan Unilever Ltd. | Diversified FMCG | 3.37% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 3.32% |
| HDFC Life Insurance Company Ltd. | Insurance | 3.27% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 3.23% |
| Maruti Suzuki India Ltd. | Automobiles | 3.17% |
Sector mix
- Financial Services 23.8%
- Healthcare 17.6%
- Fast Moving Consumer Goods 14.1%
- Power 10.6%
- Automobile and Auto Components 6.3%
- Consumer Durables 6.0%
- Construction 6.0%
- Other 15.5%
Risk metrics, trailing 3y (298 matched daily returns, 2025-08-01 → 2026-10-22)
Calmar
—
CAGR / |max DD| in window
Risk-free rate assumed 6.0% annualised. Benchmark = Nifty100 Low Volatility 30 (assigned by category mapping).
Factual data only. No investment advice or recommendation. Read the scheme document and consult a SEBI-registered Investment Adviser for personalised guidance.